{"id":5663,"date":"2006-07-06T09:07:00","date_gmt":"2006-07-06T09:07:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5663"},"modified":"2021-07-09T11:14:20","modified_gmt":"2021-07-09T11:14:20","slug":"cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/","title":{"rendered":"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hasegawa+M&amp;cauthor_id=17096695\">Midori Hasegawa<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17096695\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ohashi+A&amp;cauthor_id=17096695\">Atsushi Ohashi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kabutan+N&amp;cauthor_id=17096695\">Nao Kabutan<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hiramatsu+S&amp;cauthor_id=17096695\">Saori Hiramatsu<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kato+M&amp;cauthor_id=17096695\">Masao Kato<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Murakami+K&amp;cauthor_id=17096695\">Kazutaka Murakami<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tomita+M&amp;cauthor_id=17096695\">Makoto Tomita<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Nabeshima+K&amp;cauthor_id=17096695\">Kunihiro Nabeshima<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hiki+Y&amp;cauthor_id=17096695\">Yoshiyuki Hiki<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sugiyama+S&amp;cauthor_id=17096695\">Satoshi Sugiyama<\/a>, Ther Apher Dial. 2006 Oct;10(5):412-8.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>&nbsp;From these results, cytapheresis can be considered a safe and effective treatment for MPO-ANCA-associated vasculitis. As for the mechanism of its action, soluble tumor necrosis factor receptor 1 (sTNFR), sTNFR2 and interleukin 1 receptor antagonist were elevated soon after cytapheresis and those levels 2 h after the cytapheresis procedure were higher than before the procedure in some cases. These elevations might be related to the efficacy of cytapheresis.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17096695\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17096695\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Midori Hasegawa&nbsp;1,&nbsp;Atsushi Ohashi,&nbsp;Nao Kabutan,&nbsp;Saori Hiramatsu,&nbsp;Masao Kato,&nbsp;Kazutaka Murakami,&nbsp;Makoto Tomita,&nbsp;Kunihiro Nabeshima,&nbsp;Yoshiyuki Hiki,&nbsp;Satoshi Sugiyama, Ther Apher Dial. 2006 Oct;10(5):412-8. &nbsp;From these results, cytapheresis can be considered a safe and effective treatment for MPO-ANCA-associated vasculitis. As for the mechanism of its action, soluble tumor necrosis factor receptor 1 (sTNFR), sTNFR2 and interleukin 1 receptor antagonist were elevated soon after [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[398,243,312,390,399],"class_list":["post-5663","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-antibody","scientific_tags-complication","scientific_tags-immunology","scientific_tags-pilot","scientific_tags-vasculitis"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Midori Hasegawa&nbsp;1,&nbsp;Atsushi Ohashi,&nbsp;Nao Kabutan,&nbsp;Saori Hiramatsu,&nbsp;Masao Kato,&nbsp;Kazutaka Murakami,&nbsp;Makoto Tomita,&nbsp;Kunihiro Nabeshima,&nbsp;Yoshiyuki Hiki,&nbsp;Satoshi Sugiyama, Ther Apher Dial. 2006 Oct;10(5):412-8. &nbsp;From these results, cytapheresis can be considered a safe and effective treatment for MPO-ANCA-associated vasculitis. As for the mechanism of its action, soluble tumor necrosis factor receptor 1 (sTNFR), sTNFR2 and interleukin 1 receptor antagonist were elevated soon after [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:14:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/\",\"name\":\"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2006-07-06T09:07:00+00:00\",\"dateModified\":\"2021-07-09T11:14:20+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/","og_locale":"es_ES","og_type":"article","og_title":"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte","og_description":"Midori Hasegawa&nbsp;1,&nbsp;Atsushi Ohashi,&nbsp;Nao Kabutan,&nbsp;Saori Hiramatsu,&nbsp;Masao Kato,&nbsp;Kazutaka Murakami,&nbsp;Makoto Tomita,&nbsp;Kunihiro Nabeshima,&nbsp;Yoshiyuki Hiki,&nbsp;Satoshi Sugiyama, Ther Apher Dial. 2006 Oct;10(5):412-8. &nbsp;From these results, cytapheresis can be considered a safe and effective treatment for MPO-ANCA-associated vasculitis. As for the mechanism of its action, soluble tumor necrosis factor receptor 1 (sTNFR), sTNFR2 and interleukin 1 receptor antagonist were elevated soon after [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:14:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/","name":"Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-asociated vasculitis:A pilot study of 21 patients - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2006-07-06T09:07:00+00:00","dateModified":"2021-07-09T11:14:20+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/cytapheresis-for-the-treatment-of-myeloperoxidase-antineutrophil-cytoplasmic-autoantibody-asociated-vasculitisa-pilot-study-of-21-patients\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5663"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}